Receptor-Mediated Delivery of CRISPR-Cas9 Endonuclease for Cell-Type-Specific Gene Editing.

Autor:	Rouet R, Thuma BA; Pfizer Medicine Design , Groton , Connecticut 06340 , United States., Roy MD; Pfizer Drug Safety R&D , Groton , Connecticut 06340 , United States., Lintner NG; Pfizer Medicine Design , Cambridge , Massachusetts 02139 , United States., Rubitski DM; Pfizer Drug Safety R&D , Groton , Connecticut 06340 , United States., Finley JE; Pfizer Drug Safety R&D , Groton , Connecticut 06340 , United States., Wisniewska HM; Pfizer Medicine Design , Groton , Connecticut 06340 , United States., Mendonsa R, Hirsh A, de Oñate L, Compte Barrón J, McLellan TJ; Pfizer Medicine Design , Groton , Connecticut 06340 , United States., Bellenger J; Pfizer Medicine Design , Groton , Connecticut 06340 , United States., Feng X; Pfizer Medicine Design , Groton , Connecticut 06340 , United States., Varghese A; Pfizer Medicine Design , Groton , Connecticut 06340 , United States., Chrunyk BA; Pfizer Medicine Design , Groton , Connecticut 06340 , United States., Borzilleri K; Pfizer Medicine Design , Groton , Connecticut 06340 , United States., Hesp KD; Pfizer Medicine Design , Groton , Connecticut 06340 , United States., Zhou K, Ma N, Tu M; Pfizer Medicine Design , Cambridge , Massachusetts 02139 , United States., Dullea R; Pfizer CVMET Biology , Cambridge , Massachusetts 02139 , United States., McClure KF; Pfizer Medicine Design , Cambridge , Massachusetts 02139 , United States., Wilson RC, Liras S; Pfizer Medicine Design , Cambridge , Massachusetts 02139 , United States., Mascitti V; Pfizer Medicine Design , Groton , Connecticut 06340 , United States., Doudna JA; MBIB Division , Lawrence Berkeley National Laboratory , Berkeley , California 94720 , United States.
Jazyk:	angličtina
Zdroj:	Journal of the American Chemical Society [J Am Chem Soc] 2018 May 30; Vol. 140 (21), pp. 6596-6603. Date of Electronic Publication: 2018 May 18.
DOI:	10.1021/jacs.8b01551
Abstrakt:	CRISPR-Cas RNA-guided endonucleases hold great promise for disrupting or correcting genomic sequences through site-specific DNA cleavage and repair. However, the lack of methods for cell- and tissue-selective delivery currently limits both research and clinical uses of these enzymes. We report the design and in vitro evaluation of S. pyogenes Cas9 proteins harboring asialoglycoprotein receptor ligands (ASGPrL). In particular, we demonstrate that the resulting ribonucleoproteins (Cas9-ASGPrL RNP) can be engineered to be preferentially internalized into cells expressing the corresponding receptor on their surface. Uptake of such fluorescently labeled proteins in liver-derived cell lines HEPG2 (ASGPr+) and SKHEP (control; diminished ASGPr) was studied by live cell imaging and demonstrates increased accumulation of Cas9-ASGPrL RNP in HEPG2 cells as a result of effective ASGPr-mediated endocytosis. When uptake occurred in the presence of a peptide with endosomolytic properties, we observed receptor-facilitated and cell-type specific gene editing that did not rely on electroporation or the use of transfection reagents. Overall, these in vitro results validate the receptor-mediated delivery of genome-editing enzymes as an approach for cell-selective gene editing and provide a framework for future potential applications to hepatoselective gene editing in vivo.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu